340 related articles for article (PubMed ID: 26668509)
1. Clinicopathological characteristics of clinical early gastric cancer in the upper-third stomach.
Ichikawa D; Komatsu S; Kosuga T; Konishi H; Okamoto K; Shiozaki A; Fujiwara H; Otsuji E
World J Gastroenterol; 2015 Dec; 21(45):12851-6. PubMed ID: 26668509
[TBL] [Abstract][Full Text] [Related]
2. Fibroblast growth factor receptor 4 protein expression and clinicopathological features in gastric cancer.
Chen H; Shen DP; Zhang ZZ; Liu JH; Shen YY; Ni XZ
World J Gastroenterol; 2015 Feb; 21(6):1838-44. PubMed ID: 25684949
[TBL] [Abstract][Full Text] [Related]
3. Factors related to lymph node metastasis and the feasibility of endoscopic mucosal resection for treating poorly differentiated adenocarcinoma of the stomach.
Park YD; Chung YJ; Chung HY; Yu W; Bae HI; Jeon SW; Cho CM; Tak WY; Kweon YO
Endoscopy; 2008 Jan; 40(1):7-10. PubMed ID: 18210339
[TBL] [Abstract][Full Text] [Related]
4. Prognostic Model Based on Systemic Inflammatory Response and Clinicopathological Factors to Predict Outcome of Patients with Node-Negative Gastric Cancer.
Qu JL; Qu XJ; Li Z; Zhang JD; Liu J; Teng YE; Jin B; Zhao MF; Yu P; Shi J; Fu LY; Wang ZN; Liu YP
PLoS One; 2015; 10(6):e0128540. PubMed ID: 26075713
[TBL] [Abstract][Full Text] [Related]
5. Long-term outcomes after radical gastrectomy in gastric cancer patients with overt bleeding.
Wang L; Wang XA; Hao JQ; Zhang LN; Li ML; Wu XS; Weng H; Lv WJ; Zhang WJ; Chen L; Xiang HG; Lu JH; Liu YB; Dong P
World J Gastroenterol; 2015 Dec; 21(47):13316-24. PubMed ID: 26715815
[TBL] [Abstract][Full Text] [Related]
6. Clinicopathologic differences between early gastric remnant cancer and early primary gastric cancer in the upper third of the stomach.
Imada T; Rino Y; Hatori S; Shiozawa M; Takahashi M; Amano T; Kondo J; Kobayashi O; Sairenji M; Motohashi H
Hepatogastroenterology; 2000; 47(34):1186-8. PubMed ID: 11020911
[TBL] [Abstract][Full Text] [Related]
7. Adenocarcinoma in the middle third of the stomach--an evaluation for the prognostic significance of clinicopathological features.
Sheen-Chen SM; Chou CW; Chen MC; Chen FC; Chen YS; Chen JJ
Hepatogastroenterology; 1997; 44(17):1488-94. PubMed ID: 9356878
[TBL] [Abstract][Full Text] [Related]
8. Lymph node metastasis in gastric cancer in the upper third of the stomach--surgical treatment on the basis of the anatomical distribution of positive node.
Kitamura K; Nishida S; Yamamoto K; Ichikawa D; Okamoto K; Taniguchi H; Yamaguchi T; Sawai K; Takahashi T
Hepatogastroenterology; 1998; 45(19):281-5. PubMed ID: 9496527
[TBL] [Abstract][Full Text] [Related]
9. A preliminary study on pre-operative tumor volumetry measured by three-dimensional computer tomography in gastric cancer.
Kikuchi S; Mieno H; Moriya H; Hosoda K; Yamashita K; Watanabe M; Kubota K; Matsunaga K
Hepatogastroenterology; 2015; 62(137):214-8. PubMed ID: 25911898
[TBL] [Abstract][Full Text] [Related]
10. [Analysis of clinicopathological characteristics and prognosis of patients with gastric cancer in different locations after radical resection].
Liu XY; Liang H; Deng JY; Pan Y; Zhang L
Zhonghua Wei Chang Wai Ke Za Zhi; 2010 Mar; 13(3):181-4. PubMed ID: 20336534
[TBL] [Abstract][Full Text] [Related]
11. Optimal extent of lymph node dissection for T1 gastric cancer, with special reference to the distribution of micrometastasis, and accuracy of preoperative diagnosis for wall invasion.
Kojima N; Yonemura Y; Bando E; Morimoto K; Kawamura T; Yun HY; Ito I; Kameya T; Hayashi I
Hepatogastroenterology; 2008; 55(84):1112-7. PubMed ID: 18705341
[TBL] [Abstract][Full Text] [Related]
12. Early gastric cancer: a single-institution experience on 60 cases.
Sigon R; Canzonieri V; Rossi C
Suppl Tumori; 2003; 2(5):S23-6. PubMed ID: 12914385
[TBL] [Abstract][Full Text] [Related]
13. Prognostic factors and recurrence pattern in node-negative advanced gastric cancer.
Lee IS; Yook JH; Kim TH; Kim HS; Kim KC; Oh ST; Kim BS
Eur J Surg Oncol; 2013 Feb; 39(2):136-40. PubMed ID: 23148932
[TBL] [Abstract][Full Text] [Related]
14. Histological mixed-type as an independent prognostic factor in stage I gastric carcinoma.
Komatsu S; Ichikawa D; Miyamae M; Shimizu H; Konishi H; Shiozaki A; Fujiwara H; Okamoto K; Kishimoto M; Otsuji E
World J Gastroenterol; 2015 Jan; 21(2):549-55. PubMed ID: 25593472
[TBL] [Abstract][Full Text] [Related]
15. Better prognosis of T2 gastric cancer with preoperative diagnosis of early gastric cancer.
Tokunaga M; Hiki N; Fukunaga T; Ohyama S; Yamada K; Yamaguchi T
Ann Surg Oncol; 2009 Jun; 16(6):1514-9. PubMed ID: 19290492
[TBL] [Abstract][Full Text] [Related]
16. [Retrospective analysis of extended gastrectomy and lymphadenectomy in early gastric cancer patients].
Huang BJ; Lu C; Xu HM; Xu YY; Chen JQ
Zhonghua Wei Chang Wai Ke Za Zhi; 2007 May; 10(3):221-5. PubMed ID: 17520378
[TBL] [Abstract][Full Text] [Related]
17. Clinicopathological features and outcome of surgical treatment of 149 patients with early (pT1) gastric cancer.
Skoropad V; Berdov B; Zagrebin V
Onkologie; 2005 May; 28(5):247-52. PubMed ID: 15867480
[TBL] [Abstract][Full Text] [Related]
18. Proposal of the surgical options for primary tumor control during sentinel node navigation surgery based on the discrepancy between preoperative and postoperative early gastric cancer diagnoses.
Park JY; Ryu KW; Eom BW; Yoon HM; Kim SJ; Cho SJ; Lee JY; Kim CG; Kook MC; Choi IJ; Nam BH; Kim YW
Ann Surg Oncol; 2014 Apr; 21(4):1123-9. PubMed ID: 24366418
[TBL] [Abstract][Full Text] [Related]
19. Relationship between expression of IGFBP7 and clinicopathological variables in gastric cancer.
Sato Y; Inokuchi M; Takagi Y; Otsuki S; Fujimori Y; Yanaka Y; Kobayashi K; Higuchi K; Kojima K; Kawano T
J Clin Pathol; 2015 Oct; 68(10):795-801. PubMed ID: 26043748
[TBL] [Abstract][Full Text] [Related]
20. Gastric Remnant Cancer: Continuing Serious and Insidious Problem for Surgeons.
Oymaci E; Sari E; Uçar AD; Erkan N; Yildirim M
Hepatogastroenterology; 2015 May; 62(139):727-31. PubMed ID: 26897962
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
